| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |